These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17009253)

  • 21. Effects of l-Carnitine Supplementation on Serum Inflammatory Factors and Matrix Metalloproteinase Enzymes in Females with Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.
    Malek Mahdavi A; Mahdavi R; Kolahi S
    J Am Coll Nutr; 2016; 35(7):597-603. PubMed ID: 26933897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis.
    Kong SY; Stabler TV; Criscione LG; Elliott AL; Jordan JM; Kraus VB
    Arthritis Rheum; 2006 Aug; 54(8):2496-504. PubMed ID: 16868970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A low cartilage formation and repair endotype predicts radiographic progression of symptomatic knee osteoarthritis.
    Luo Y; Samuels J; Krasnokutsky S; Byrjalsen I; Kraus VB; He Y; Karsdal MA; Abramson SB; Attur M; Bay-Jensen AC
    J Orthop Traumatol; 2021 Mar; 22(1):10. PubMed ID: 33687578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Salmon Calcitonin and Omega - 3 Fatty Acids on Glucoregulatory Indices, Lipid Profile and Antioxidant Markers in Experimental Knee Osteoarthritis in Wistar Rats.
    Adeyemi WJ; Olayaki LA
    Niger J Physiol Sci; 2017 Dec; 32(2):179-188. PubMed ID: 29485639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 12-week randomized, double-blind, placebo-controlled multicenter study of choline-stabilized orthosilicic acid in patients with symptomatic knee osteoarthritis.
    Geusens P; Pavelka K; Rovensky J; Vanhoof J; Demeester N; Calomme M; Vanden Berghe D
    BMC Musculoskelet Disord; 2017 Jan; 18(1):2. PubMed ID: 28056936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levels of metalloproteinase (MMP-3, MMP-9), NF-kappaB ligand (RANKL), and nitric oxide (NO) in peripheral blood of osteoarthritis (OA) patients.
    Li H; Li L; Min J; Yang H; Xu X; Yuan Y; Wang D
    Clin Lab; 2012; 58(7-8):755-62. PubMed ID: 22997976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The release of crosslinked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis.
    Lohmander LS; Atley LM; Pietka TA; Eyre DR
    Arthritis Rheum; 2003 Nov; 48(11):3130-9. PubMed ID: 14613275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study.
    Mazières B; Hucher M; Zaïm M; Garnero P
    Ann Rheum Dis; 2007 May; 66(5):639-45. PubMed ID: 17204566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cartilage oligomeric matrix protein and hyaluronic acid are sensitive serum biomarkers for early cartilage lesions in the knee joint.
    Jiao Q; Wei L; Chen C; Li P; Wang X; Li Y; Guo L; Zhang C; Wei X
    Biomarkers; 2016; 21(2):146-51. PubMed ID: 26634947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhalation therapy of calcitonin relieves osteoarthritis of the knee.
    Armagan O; Serin DK; Calisir C; Dokumacioglu A; Ozgen M; Oner S; Alatas O
    J Korean Med Sci; 2012 Nov; 27(11):1405-10. PubMed ID: 23166425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial.
    Garnero P; Aronstein WS; Cohen SB; Conaghan PG; Cline GA; Christiansen C; Beary JF; Meyer JM; Bingham CO
    Osteoarthritis Cartilage; 2008 Jun; 16(6):660-6. PubMed ID: 17993283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study.
    Karsdal MA; Byrjalsen I; Henriksen K; Riis BJ; Lau EM; Arnold M; Christiansen C
    Osteoarthritis Cartilage; 2010 Feb; 18(2):150-9. PubMed ID: 19747581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis--association with disease progression.
    Sharif M; Kirwan J; Charni N; Sandell LJ; Whittles C; Garnero P
    Rheumatology (Oxford); 2007 Jun; 46(6):938-43. PubMed ID: 17387119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and biochemical characteristics after intra-articular injection for the treatment of osteoarthritis of the knee: prospective randomized study of sodium hyaluronate and corticosteroid.
    Shimizu M; Higuchi H; Takagishi K; Shinozaki T; Kobayashi T
    J Orthop Sci; 2010 Jan; 15(1):51-6. PubMed ID: 20151251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between concentrations of urinary type II collagen neoepitope (uTIINE) and joint space narrowing in patients with knee osteoarthritis.
    Hellio Le Graverand MP; Brandt KD; Mazzuca SA; Katz BP; Buck R; Lane KA; Pickering E; Nemirovskiy OV; Sunyer T; Welsch DJ
    Osteoarthritis Cartilage; 2006 Nov; 14(11):1189-95. PubMed ID: 16753310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early effect of hyaluronic acid intra-articular injections on serum and urine biomarkers in patients with knee osteoarthritis: An open-label observational prospective study.
    Conrozier T; Balblanc JC; Richette P; Mulleman D; Maillet B; Henrotin Y; Rannou F; Piroth C; Hilliquin P; Mathieu P; Walliser-Lohse A; Rousselot I; Plattner V; Maillefert JF; Vignon E; Chevalier X;
    J Orthop Res; 2012 May; 30(5):679-85. PubMed ID: 22025307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.
    Garnero P; Gineyts E; Christgau S; Finck B; Delmas PD
    Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigations of inter- and intraindividual relationships between exposure to oral salmon calcitonin and a surrogate marker of pharmacodynamic efficacy.
    Karsdal MA; Byrjalsen I; Henriksen K; Riis BJ; Christiansen C
    Eur J Clin Pharmacol; 2010 Jan; 66(1):29-37. PubMed ID: 19813008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo.
    Uebelhart D; Malaise M; Marcolongo R; de Vathaire F; Piperno M; Mailleux E; Fioravanti A; Matoso L; Vignon E
    Osteoarthritis Cartilage; 2004 Apr; 12(4):269-76. PubMed ID: 15023378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety, tolerability, and pharmacodynamics of an anti-interleukin-1α/β dual variable domain immunoglobulin in patients with osteoarthritis of the knee: a randomized phase 1 study.
    Wang SX; Abramson SB; Attur M; Karsdal MA; Preston RA; Lozada CJ; Kosloski MP; Hong F; Jiang P; Saltarelli MJ; Hendrickson BA; Medema JK
    Osteoarthritis Cartilage; 2017 Dec; 25(12):1952-1961. PubMed ID: 28964890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.